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Abstract  In  the  last  years,  a  distinctive  interest  has  been  raised  on  large  polypoid  and  non-
polypoid  colorectal  tumors,  and  specially  on  ﬂat  neoplastic  lesions  ≥20  mm  tending  to  grow
laterally, the  so  called  laterally  spreading  tumors  (LST).  Real  or  virtual  chromoendoscopy,  endo-
scopic ultrasound  or  magnetic  resonance  should  be  considered  for  the  estimation  of  submucosal
invasion of  these  neoplasms.  Lesions  suitable  for  endoscopic  resection  are  those  conﬁned  to
the mucosa  or  selected  cases  with  submucosal  invasion  ≤1000  m.  Polypectomy  or  endoscopic
mucosal resection  remain  a  ﬁrst-line  therapy  for  large  colorectal  neoplasms,  whereas  endo-
scopic submucosal  dissection  in  high-volume  centers  or  surgery  should  be  considered  for  large
LSTs for  which  en  bloc  resection  is  mandatory.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
PALAVRAS-CHAVE
Endoscopia
Gastrointestinal;
Lesões  Colorretais  Grandes:  Avaliac¸ão  e  Tratamento
Resumo  Nos  últimos  anos  houve  um  crescente  interesse  pelas  lesões  colorretais  polipoides  e
Neoplasias
Colorrectais;
Pólipos  do  Colon
não polipoides  de  grande  tamanho,  especialmente  pelas  lesões  planas  neoplásicas  ≥20  mm  que
tendem a  crescer  lateralmente  -  as  chamadas  lesões  de  espraiamento  lateral  (LST).  Para  avaliar
o acometimento  submucoso  dessas  lesões,  pode-se  utilizar  a  cromoendoscopia  real  ou  virtual,
a ecoendoscopia  e  a  ressonância  magnética.  A  ressecc¸ão  endoscópica  está  indicada  em  lesões
restritas à  mucosa  ou  em  casos  selecionados  com  invasão  da  submucosa  ≤  1000  m.  A  polipec-
ópica  de  mucosa  permanecem  um  tratamento  de  primeira  escolhatomia e  a  ressecc¸ão  endosc∗ Corresponding author.
E-mail address: jpereiralima@terra.com.br (J.C. Pereira-Lima).
http://dx.doi.org/10.1016/j.jpge.2016.01.001
2341-4545/© 2016 Sociedade Portuguesa de Gastrenterologia. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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para  lesões  colorretais  grandes,  enquanto  que  as  LSTs  cuja  ressecc¸ão  em  bloco  é  mandatória
devem ser  submetidas  à  dissecc¸ão  submucosa  endoscópica  em  centros  com  grande  experiência
na técnica  ou  à  ressecc¸ão  cirúrgica.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este
e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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International  Colorectal  Endoscopic)  type  III.  This  guide-
line  suggests,  as  already  pointed  out  by  Japanese  authors,12
that  biopsies  should  be  used  with  caution,  since  they  can
cause  ﬁbrosis  in  the  biopsied  area  and  thus,  prevents
Figure  1  Polypoid  lesion  type  0-Is.. Introduction
olorectal  cancer  (CRC)  is  a  major  cause  of  cancer-related
orbidity  and  mortality.1 It  affects  mainly  people  older
han  50  years  and  the  detection  and  removal  of  precur-
or  colorectal  lesions  has  enabled  a  signiﬁcant  reduction  in
he  incidence  of  cancer  and  in  the  CRC-related  mortality
f  these  cases.2 The  characteristics  of  the  removed  lesions
nd  its  histopathology  determine  colonoscopy  surveillance.
 recent  guideline3 indicates  shorter  intervals  for  advanced
eoplasms  (adenomas  ≥10  mm,  villous  histology  or  high-
rade  dysplasia,  and  cancer).  In  addition  to  these  criteria,
he  presence  of  three  or  more  adenomas  and  serrated  polyps
10  mm  fulﬁll  the  requirements  for  the  high-risk  group.
hus,  large  lesions  (≥2.0  cm)  are  considered  high-risk  neo-
lasms,  with  potential  for  malignancy,  submucosal  invasion
nd  lymphatic  involvement,  being  the  risk  of  harboring  car-
inoma  as  high  as  20--50%.4 Lesions  are  called  superﬁcial
hen  their  features  at  endoscopy  suggest  that  they  are
imited  to  the  mucosa  or  submucosa.  These  lesions  may  be
olypoid  (sessile,  pedunculated  and  subpedunculated)  and
on-polypoid  (ﬂat  or  depressed).  Techniques  for  resection
f  these  large  lesions  can  use  a  diathermy  loop  for  pedun-
ulated  or  subpedunculated  lesions,  and  the  method  of
ndoscopic  mucosal  resection  or  submucosal  dissection  for
essile  and  non-polypoid  lesions.5,6
. Evaluation of large colorectal lesions
ccording  to  the  Paris  classiﬁcation,7 lesions  greater  than
.5  mm  in  height  are  considered  polypoid;  they  can  be  mea-
ured  by  positioning  a  closed  biopsy  forceps  next  to  the
esion.  They  are  more  frequent  in  the  left  colon  and  are
lassiﬁed  as  type  0-Is  (sessile),  type  0-Ip  (pedunculated)  and
ype  0-Isp  (subpedunculated)  (Figs.  1--2).
Non-polypoid  lesions  ≥20  mm  in  diameter  are  deﬁned
s  laterally  spreading  tumors  (LSTs),  which  are  character-
zed  by  a  lateral  and  circumferential  growth  in  the  colonic
all,  with  deep  invasion  of  the  submucosa  occurring  only
t  later  stages,  and  are  more  commonly  diagnosed  at  the
ight  colon.  LSTs  are  classiﬁed  as  granular  (LST-G)  and
on-granular  (LST-NG)  types,  according  to  the  presence  or
bsence  of  a  granular  surface  pattern.  Kudo  et  al.8 proposed
 sub-classiﬁcation  of  LSTs,  in  which  LST-Gs  are  classiﬁed
s  homogeneous  and  nodular  mixed  subtypes  (LST-G-N),  and
ST-NGs  are  classiﬁed  as  ﬂat  elevated  and  pseudo  depressed
ubtypes  (LST-NG-PD)(Fig.  3A--C).  The  LST-G-N  and  the  LST-
G-PD  have  a  higher  potential  for  malignancy.9 The  rate Ff  invasive  carcinoma  in  LST-Gs  is  low,  and  most  cases  are
onsidered  adenomatous  lesions,  where  the  homogeneous
ubtype  tends  to  be  a tubular  adenoma,  and  the  nodular
ixed  subtype  tends  to  have  villous  features.10
The  British  Society  of  Gastroenterology  guidelines11 sug-
est  that  the  term  ‘‘non-pedunculated  colorectal  polyp’’
NPCP)  is  the  most  appropriate  term  to  deﬁne  sessile  and
at  lesions,  so  the  term  ‘‘large  NPCP’’  may  be  used  to
escribe  NPCP  >  2.0  cm.  This  guideline  considered  the  non-
ranular  and  granular  nodular  mixed  subtype  LST  as  having
n  increased  risk  for  malignancy,  as  well  as,  pit  patterns
ype  V,  capillary  pattern  Sano’s  type  III  and  NICE  (NBIigure  2  Polypoid  lesion  type  0-Ip.
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Figure  3  (A)  Granular  homogeneous  Laterally  Spreading  Tumor  (LST)  subtype;  (B)  Granular  nodular-mixed  LST  subtype;
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sis  of  neoplastic  and  non-neoplastic  lesions.  Yoshida  et  al.
18(C) Non-granular  ﬂat  elevated  LST  subtype.
endoscopic  resection.  When  biopsies  are  necessary,  they
should  be  directed  to  the  area  exhibiting  features  indicative
of  cancer,  avoiding  ﬂat  areas  and  the  lesion  periphery.
With  respect  to  early  CRC  it  is  important  to  distinguish
the  presence  or  absence  of  deep  submucosal  invasion.  Stud-
ies  have  shown  that  pit  and  capillary  pattern  analysis  using
image  magniﬁcation  is  useful  in  diagnosing  early  invasive
colorectal  cancer13,14 (Figs.  4--5).  These  factors  help  in
determining  the  therapeutic  approach.15 Size  is  an  impor-
tant  independent  factor  related  to  non-lifting  sign.  Ferrara
16F  et  al. showed  this  relationship  in  lesions  ≥  25  mm.
Furthermore,  according  to  guidelines  of  the  Japan  Gastroen-
terological  Endoscopy  Society  (JGES),12 using  magnifying
endoscopy,  known  as  optical  biopsy,  is  more  effective  and
Figure  4  Pit  pattern  type  Vn  (Kudo’s  Classiﬁcation).  Adeno-
carcinoma  with  massive  invasion  of  the  submucosa.
s
8
F
tighly  accurate  both  for  distinction  between  adenoma  and
denocarcinoma  and  for  evaluation  of  invasion  depth,  than
arrying  out  a  simple  biopsy,  which,  in  addition  to  not  provid-
ng  a  qualitative  diagnosis,  may  cause  ﬁbrosis,  thus  hindering
ndoscopic  treatment.
High  deﬁnition  colonoscopy  and  chromoendoscopy  are
lso  widely  used  in  the  Western  world.  Averbach  M  et  al.
7 had  79.7%  accuracy,  88.8%  sensitivity,  55%  speciﬁcity,  a
PP  of  84.2%  and  a  VPN  of  64.7%  in  the  differential  diagno-studied  the  surface  pattern  of  151  polyps  using  the  FICE
ystem  without  magniﬁcation  and  reported  an  accuracy  of
9.4%.
igure  5  Capillary  pattern  type  C3  (Hiroshima’s  Classiﬁca-
ion). Adenocarcinoma  with  massive  invasion  of  the  submucosa.
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A  recent  study  showed  similar  accuracy  for  measuring
nvasion  depth  of  early  CCR  when  comparing  magnifying
hromoendoscopy  and  EUS,  in  terms  of  submucosal  invasion
epth  < 1000  m  (both  with  accuracy  =  71.2%)  and  deeper
nvasion  (accuracy  of  68.6%  vs  70.9%,  respectively).22 Other
 prospective  studies  comparing  these  techniques  demon-
trated  signiﬁcant  better  ﬁgures  for  EUS.23,24
Endoscopic  ultrasound  (EUS)  and  Magnetic  resonance
maging  (MRI)  are  comparable  in  terms  of  accuracy  and
afety  in  the  evaluation  of  wall  penetration  and  perirectal
odal  involvement  and,  consequently  inﬂuence  the  manage-
ent  strategy.25,26 Both  techniques  present  similar  results
or  T  and  N  staging  of  rectal  cancer.  EUS  performs  better
han  MRI  in  T1  cancers,  whereas  MRI  has  better  results  with
4  lesions.  So,  to  study  rectal  early  cancer  EUS  technique
an  help  more  to  indicate  an  endoscopic  treatment  or  a mini-
ally  invasive  surgical  procedure.25 Mukae  et  al.26 estimated
he  invasion  depth  of  714  cases  of  early  CRC  on  EUS  and
howed  an  overall  diagnostic  accuracy  of  89%.  Their  results
ere  signiﬁcantly  higher  for  rectal  tumors,  for  protruding
umors  and  LSTs,  and  Tis  cancer.
.1.  Risk  evaluation
tudies  have  shown  a  strong  correlation  between  lesion  size
nd  its  potential  for  malignancy,19--21 and  larger  lesions  are
onsidered  to  be  at  higher  risk  for  submucosal  invasion  and
ymph  node  involvement.27 A  greater  malignant  potential
or  lesions  >10  mm  (p  <  0.0001)  was  observed  by  Reinhart
t  al.,28 regardless  of  morphology.  However,  there  have  been
eries  showing  that  small,  non-polypoid  lesions  are  more
ikely  to  contain  carcinoma  and  a  deeper  inﬁltration  of  the
ubmucosa,  when  compared  to  larger  polypoid  lesions.29--31
urisu  et  al.29 have  investigated  the  development  and  pro-
ression  of  early  CRC,  and  observed  that  non-polypoid
esions  were  signiﬁcantly  smaller  than  polypoid  ones  and
resented  with  deeper  invasion  of  the  submucosa.  Soeti-
no  et  al.31 have  also  found  that  non-polypoid  lesions  were
ore  likely  to  contain  carcinoma  (OR  =  9.78)  than  poly-
oid  ones,  regardless  of  their  size.  Santos  et  al.32 showed
hat  the  presence  of  advanced  histology  was  signiﬁcantly
ore  frequent  in  non-polypoid  neoplasms  than  in  polypoid
esions  (p  =  0.007).  The  probability  of  non-polypoid  lesions
aving  advanced  histology  was  twice  higher  (p  =  0.007),
nd  when  non-polypoid  lesions  were  classiﬁed  as  ﬂat  or
epressed  type,  presence  of  high-grade  dysplasia  or  cancer
as  detected  in  2%  and  41.3%  of  the  lesions,  respectively,
hile  being  detected  in  1.9%  of  polypoid  lesions.  However,
hen  considering  this  risk  for  depressed  lesions,  advanced
istology  was  36-fold  more  likely  to  occur  in  this  type  of
on-polypoid  lesion.  Matsuda  et  al.30 have  shown  a  simi-
ar  aggressiveness  and  malignant  potential  when  comparing
maller  and  larger  lesions.
Santos  et  al.32 found  four  (5.3%)  adenocarcinomas  among
he  76  neoplasms  ≥20  mm,  and  29  (38.2%)  adenomas
ith  high-grade  dysplasia.  Therefore,  43.4%  presented  with
dvanced  histology.  All  adenocarcinomas  were  located  in
he  left  colon,  but  only  one  lesion  had  massively  invaded
he  submucosa  (1.3%).  In  the  study  by  Ahlawat  et  al.,33 183
esions  of  the  colon  and  rectum  ≥20  mm,  most  of  them  ses-
ile,  were  removed  endoscopically,  and  the  rate  of  invasive
arcinoma  was  10%.
(
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e
cC.E.O.  dos  Santos  et  al.
Luigiano  et  al.34 have  shown  increased  malignancy  in
essile  polypoid  lesions  when  compared  to  non-polypoid,
uperﬁcial  lesions  (21.6%  vs  6%,  p  =  0.0013).  Another  series
as  examined  the  risk  of  lymph  node  metastases  in  patients
ith  invasive  pedunculated  polypoid  type  CRC.  Among  the
atients  that  were  treated  surgically,  the  incidence  of  lymph
ode  metastases  was  3.5%  (8/230);  however,  the  incidence
as  0%  (0/101)  in  patients  with  invasion  of  the  polyp  head
nd  6.2%  (8/129)  when  the  invasion  occurred  at  the  polyp
talk.35 Caputi  et  al.19 have  reported  malignancy  in  9.3%  of
esions  ≥20  mm,  with  3.3%  of  invasive  carcinomas.
There  was  no  statistical  difference  when  comparing  the
ite  of  the  neoplasms  with  the  occurrence  of  advanced  his-
ology,  but  all  15  polypoid  tumors  with  advanced  histology
ere  located  in  the  left  colon,  whereas  72.2%  (13/18)  of
on-polypoid  neoplasms  were  in  the  right  colon.40 This  was
orroborated  by  Rondagh  et  al. 36, who  found  that  proximal
eoplasms  with  advanced  histology  were  more  likely  to  be
on-polypoid  (OR  4.68,  p  =  0.006).
Chung  et  al.37 have  shown  a  6-fold  higher  incidence  of
etachronous  advanced  neoplasms  for  patients  in  the  high-
isk  group,  when  compared  to  individuals  without  adenomas
t  the  index  colonoscopy,  considering  that  the  size  ≥10  mm
s  an  independent  predictor.
Martinez  et  al.38 have  observed  a  15.5%  risk  of  advanced
eoplasm  during  follow-up  in  the  high-risk  group  and  of
.9%  in  the  low  risk  group.  The  risk  of  invasive  cancer  was
.2%  in  patients  who  had  adenomas  ≥20  mm  at  the  index
olonoscopy  and  1.3%  in  patients  who  presented  lesions
ith  high-grade  dysplasia.  Compared  to  patients  with  ade-
omas  smaller  than  20  mm  at  the  baseline  colonoscopy,  the
djusted  probability  for  advanced  neoplasm  was  2.99.
. Management
he  discontinuation  or  not  of  anti-thromboembolic  therapy
efore  endoscopic  resection  should  be  performed  as  recom-
ended  by  published  guidelines.  The  European  Society  of
astrointestinal  Endoscopy  (ESGE)  guideline39 recommends
hat  the  management  of  antiplatelet  agents  (APA)  should
e  based  on  the  thrombotic  risk  of  the  patient  and  the  risk
f  bleeding  of  the  procedure.  To  patients  with  low  throm-
otic  risk  (Coronary  DES  >  12  months  previously,  bare  metal
oronary  stents  inserted  >  6  weeks  previously  without  asso-
iated  risk  factors,  stroke  without  cardiac  failure  >  6  weeks
reviously)  in  endoscopy  with  high  bleeding  risk  (EUS-FNA
f  cysts,  EMR  and  ESD)  the  recommendations  are  to  stop
spirin  5  days  prior  to  the  procedure;  in  patients  taking
hienopyridine  alone,  it  is  recommended  to  substitute  it
or  aspirin.  Patients  with  high  thrombotic  risk  (Coronary
ES  performed  ≤  12  months  previously,  bare  metal  coronary
tents  inserted  ≤  6  weeks  previously  or  >6  weeks  with  associ-
ted  risk  factors,  stoke  ≤  6  weeks  previously)  and  with  high
leeding  risk,  the  procedure  should  be  delayed  and/or  a
ardiologist  should  be  consulted  to  discuss  temporary  cessa-
ion  of  a thienopyridine.  Aspirin  should  be  maintained  in  all
ases.  The  American  Society  for  Gastrointestinal  Endoscopy
ASGE)  guideline40 recommends  that  clopidogrel  or  ticlo-
idine  should  be  removed  for  about  7--10  days  before  an
lective  procedure  in  patients  with  a  recently  placed  vas-
ular  stent  or  acute  coronary  syndrome.  The  APA  may  be
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reinitiated  as  soon  as  deemed  safe  with  consideration  of
the  patient’s  condition.  Warfarin  anticoagulation  should  be
suspended  in  patients  with  a  low  risk  of  thromboembolic
complications  in  the  periendoscopic  period,  but  the  ASGE
suggests  continuing  the  anticoagulation  in  patients  at  higher
risk  of  thromboembolic  events,  switching  to  unfractionated
heparin  and  low  molecular  weight  heparin  before  the  endo-
scopic  procedure.
4. Endoscopic treatment modalities
4.1.  Polypectomy
It  is  the  technique  indicated  for  pedunculated  or  subpe-
dunculated  lesions.  The  most  common  method  of  removing
colon  polyps  is  endoscopic  resection,  such  as  snare
resection,  among  others,  with  or  without  ﬂuid  injection  into
the  submucosal  layer.  Pedunculated  polyps  have  the  feeding
artery  running  through  the  pedicle.  Safety  and  effective-
ness  of  endoscopic  polypectomy  of  large  colorectal  polyps
should  be  the  main  goals  of  this  procedure,  where  diather-
mal  snare  is  the  most  used  accessory.  The  most  common
complication  after  polypectomy  is,  by  far,  hemorrhage,  and
bleeding  is  oftener  after  polypectomy  for  large  polyps  with
a  thick  pedicle.
4.2.  Endoscopy  mucosal  resection  (EMR)
EMR  is  a  minimally  invasive,  easy-to-learn,  safe  and  effec-
tive  technique  used  in  the  treatment  of  premalignant  lesions
and  early  carcinomas  that  have  a  low  risk  of  lymph  node
metastasis.  The  most  common  technique  is  the  ‘inject  and
cut’  EMR,  originally  described  in  1973  by  Deyhle  et  al.41.  This
technique  involves  the  injection  of  saline  solution  into  the
submucosal  layer  under  the  lesion  to  be  removed  in  order
to  lift  the  lesion  and  create  a  ﬂuid  cushion  between  the
mucosa  and  the  muscular  wall,  mitigating  thermal  effects
on  the  organ  wall,  thus  reducing  the  risk  of  perforation
and  bleeding  and  facilitating  en  bloc  resection  of  lesions.
Hyaluronic  acid,  glycerol,  and  hydroxypropylmethylcellu-
lose  (HPMC)  are  other  injection  options  and  appear  to
have  a  more  durable  cushioning  effect.  Unfortunately,  these
agents  are  expensive  and  are  not  readily  available  in  most
Endoscopy  units,  and  are  difﬁcult  to  inject.  A  compara-
tive  study  between  a  hypertonic  solution  and  saline  solution
showed  a  lower  volume  of  ﬂuid  injected  into  the  submu-
cosa  in  the  former  solution  (p  =  0.033),  fewer  injections  were
needed  to  maintain  the  submucosal  elevation,  especially  in
lesions  >  40  mm  (p  =  0.039),  and  submucosal  elevation  time
was  longer  (p  =  0.043).42
EMR  is  a  less  invasive  alternative  to  surgical  removal
of  adenomas,  including  large-size  tumors,43--47 intramu-
cosal  carcinoma,  and  minimally  invasive  submucosal
carcinoma.47--49 Furthermore,  Tanaka  et  al.50 reported
that  well-  or  moderately  differentiated  carcinomas  within
1500  m  invasion  are  curatively  treated  by  EMR,  provided
that  no  vascular  involvement  is  observed.  EMR  has  repre-
sented  a  major  advance  in  therapy  by  allowing  the  resection
of  superﬁcial  lesions  and  also  allowing  the  removal  of
large  sessile  lesions  and  laterally  spreading  tumors  (LST).
These  larger  lesions  may  be  removed  in  pieces  (piecemeal
h
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esection).  This  method  has  made  endoscopic  treatment
afer,  minimizing  the  risk  of  complications.  To  conﬁrm  recur-
ence  (or  residual  neoplasm)  follow-up  colonoscopy  should
e  done  between  2  and  6  months  after  resection  by  the
iecemeal  technique.11,12
En  bloc  resection  is  the  optimal  treatment  of  colo-
ectal  neoplasms,  especially  adenocarcinomas,  facilitating
istopathological  diagnosis  and  allowing  lymphovascular
nvasion  and  invasion  depth  to  be  properly  evaluated.
esions  up  to  20  mm  in  size  can  be  easily  removed  en  bloc
y  EMR.  The  choice  between  piecemeal  EMR  and  endoscopic
ubmucosal  dissection  (ESD)  for  large  LSTs  should  be  based
n  LST  subtype  and,  when  indicated,  on  magniﬁcation  chro-
oendoscopy,  as  well  as  local  expertise.12
Most  LSTs  are  of  the  granular  type  and  are  more  frequent
n  the  right  colon.51 Previous  studies51,52 have  identiﬁed
arge  lesions,  with  pseudo  depression  and  large  nodules
≥10  mm),  as  predictors  of  higher  aggressiveness  of  LSTs,
ut  most  LSTs  are  adenomatous  lesions,  even  when  they
each  large  diameters,  allowing  endoscopic  resection  to
e  performed.  Prior  to  selection  of  the  resection  tech-
ique,  it  is  important  to  distinguish  between  adenoma
nd  adenocarcinoma.  Virtual  chromoendoscopy  or  real-
ime  chromoendoscopy  (using  indigo  carmine)  allow  deﬁning
heir  pit  and  capillary  patterns,  inﬂuencing  the  choice  of
pproach  to  LST  management.
.3.  Endoscopic  submucosal  dissection  (ESD)
n  ESD  technique,  the  solution  is  injected  into  the  submucosa
f  a tumor  through  the  injection  needle.  The  circumference
f  the  lesion  is  incised  using  a  knife  for  ESD  with  electri-
al  cutting  current,  and  the  submucosal  layer  is  dissected.
his  technique  can  resect  the  lesion  in  one  piece  regard-
ess  of  its  size  and  shape.  When  it  starts  dissecting  the
ubmucosa  and  after  circumferential  incision  of  the  lesion,
he  resection  is  ﬁnished  using  a  snare,  it  is  called  hybrid
SD.
The  traditional  and  most  commonly  used  ﬂuid  for  submu-
osal  injection  for  endoscopic  resection  of  large  colorectal
olyps  is  saline  solution;  however,  it  is  difﬁcult  to  maintain
dequate  mucosal  elevation,  due  to  its  rapid  absorption.  A
rolonged  submucosal  elevation  provides  an  advantage  for
he  resection  of  large  and  giant  sessile  lesions,  because  it  is
ess  often  necessary  to  interrupt  the  procedure  by  injecting
ore  submucosal  ﬂuid  and  maintain  the  elevation.  This  is
chieved  by  hypertonic  solutions,  such  as  hypertonic  saline
olution  and  dextrose  water  >15%.53
ESD  is  indicated  for  lesions  >20  mm,  lesions  that  are
ifﬁcult  to  be  removed  en  bloc  by  EMR,  lesions  with
ype  Vi  pit  pattern  (irregular  arrangement  --  Kudo’s  Clas-
iﬁcation),  carcinomas  with  shallow  submucosal  invasion,
ucosal  tumors  with  ﬁbrosis,  and  recurrent  or  residual
arly  carcinomas  after  endoscopic  resection.9,12 A  Japanese
ulticentre  study54 demonstrated  a  signiﬁcantly  higher  en
loc  resection  rate  with  ESD  than  with  conventional  endo-
copic  resection  (94.5%  vs  56.9%,  p  <  0.01).  Saito  Y  et  al.55ad  en  bloc  resection  and  curative  rates  (R0)  of  90%  and
7%,  respectively.  Toyonaga  et  al.56 observed  that  procedure
ime  was  faster  in  hybrid  ESD  (p  <  0.0001),  but  the  en  bloc
esection  rate  was  signiﬁcantly  higher  in  ESD  than  in  hybrid
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SD  (p  =  0.0044).  The  complication  rate  in  hybrid  ESD  tended
o  be  higher,  but  without  reaching  statistical  signiﬁcance.
LST-G-N  with  large  nodule  and  LST-NG-PD,  which  may
ave  multifocal  submucosal  invasion,  whose  foci  are  often
ifﬁcult  to  detect,  should  be  removed  preferably  by  en  bloc
esection,  for  which  ESD  is  indicated,  with  reduced  recur-
ence  rates.9
The  ESGE  states  that  the  majority  of  colonic  and  rectal
uperﬁcial  lesions  can  be  effectively  removed  in  a  cura-
ive  way  by  standard  polypectomy  and/or  by  EMR  (strong
ecommendation,  moderate  quality  evidence).  ESD  can  be
onsidered  for  removal  of  colonic  and  rectal  lesions  with
igh  suspicion  of  limited  submucosal  invasion  that  is  based
n  two  main  criteria  of  depressed  morphology  and  irregular
r  nongranular  surface  pattern,  particularly  if  the  lesions
re  larger  than  20  mm;  or  ESD  can  be  considered  for  colorec-
al  lesions  that  otherwise  cannot  be  optimally  and  radically
emoved  by  snare-based  techniques  (strong  recommenda-
ion,  moderate  quality  evidence).57
The  ESD  technique,  however,  is  more  complex  than  EMR
nd  has  been  associated  with  a  long  learning  curve;  long  pro-
edure  time  and  signiﬁcantly  more  complications,  especially
erforation,58 and  its  use  should  be  limited  to  specialized
enters.  So,  when  ESD  expertise  is  not  available,  EMR  piece-
eal  technique  is  a  good  option  for  the  treatment  of  LSTs.
ndoscopic  resection  should  be  tried  and  the  ﬁnal  decision
aken  after  pathologic  evaluation.
. Surgical techniques
n  two  metanalytic  reviews,  the  disease-free  and  overall
urvival  rates  for  stages  I,  II,  and  III  colon  cancer  did  not
iffer  when  comparing  laparoscopic-assisted  vs  open  colec-
omy.  So,  laparoscopically  assisted  colectomy  for  cancer  is
ncologically  safe.59,60
Transanal  endoscopic  microsurgery  (TEM)  is  a  minimally
nvasive  technique  for  excision  of  rectal  tumors  that  avoids
onventional  pelvic  resectional  surgery  along  with  its  risks
nd  side  effects.  Sajid  MS  et  al.61 observed  a  higher  risk  of
ocal  recurrence  (p  <  0.003)  and  overall  recurrence  (p  <  0.01)
ollowing  this  technique  compared  with  radical  surgery  (RR).
he  risk  of  distant  recurrence,  overall  survival  and  mortality
ere  similar.  TEM  was  associated  with  a  shorter  operation
ime  and  hospital  stay  and  a  reduced  risk  of  postoperative
omplications  (p  <  0.0001).
A  systematic  review  has  not  shown  difference  between
EM  and  transanal  excision  in  the  postoperative  complica-
ion  rate.  TEM  had  a  higher  rate  of  negative  microscopic
argins  (p  <  0.001),  had  a  reduced  rate  of  specimen  frag-
entation  (p  <  0.001)  and  lesion  recurrence  (p  <  0.001)
ompared  with  transanal  excision.62
Transanal  minimally  invasive  surgery  (TAMIS)  has  emerged
s  an  alternative  to  TEM  for  resection  of  benign  polyps  and
arly  cancers  of  the  rectum.  This  technique  uses  ordinary
aparoscopic  instruments  to  achieve  high-quality  local  exci-
ion.  In  a  recent  study  no  difference  was  observed  between
he  two  techniques  regarding  the  accuracy  of  dissection,  but
issection  and  suturing  were  signiﬁcantly  quicker  in  the  TEM
roup.63
Kawaguti  et  al.64 showed  en  bloc  resection  rates  with
ree  margins  in  81.8%  of  patients  in  the  ESD  group  and  84.6%
f  patients  in  the  TEM  group  (p  =  0.40).  No  difference  was
r
s
i
dC.E.O.  dos  Santos  et  al.
bserved  regarding  mean  tumor  size  (p  =  0.13),  local  recur-
ence,  mean  procedure  time  (p  =  0.69)  and  mean  hospital
tay  (p  =  0.81).
.1.  Recurrence
ecurrence  (or  residual  neoplasm)  was  deﬁned  as  the  pres-
nce  of  neoplastic  tissue  in  the  area  of  previous  resection,
s  diagnosed  by  follow-up  colonoscopy.  Lesions  that  have
n  increased  risk  of  incomplete  resection  or  recurrence
re  lesions  >  40  mm,  those  involving  the  ileocecal  valve,  the
ppendix,  a  diverticulum  or  the  dentate  line.11 The  non-
ifting  sign  after  submucosal  injection,  prior  failed  attempt
f  resection  or  recurrence  at  the  site  of  previous  resection
re  also  associated  with  disease  recurrence.
Recurrence  ranges  in  the  literature  from  1.2  to  55%
ccording  to  a  variety  of  risk  factors.34,46,65--67 Most
eries  have  reported  a  higher  recurrence  rate  associ-
ted  with  piecemeal  resection  as  compared  with  en  bloc
esection.16,34,68 On  the  other  hand,  Lim  et  al.69 found  no
ifference  between  the  two  techniques.
In  our  experience,15 it  was  observed  a  greater  recurrence
ate  with  piecemeal  EMR  (p  <  0.01),  advanced  neoplasms
p  =  0.01),  and  carcinomas  (p  =  0.04).  Piecemeal  resection  of
alignancy  was  identiﬁed  as  an  independent  risk  factor  for
ncomplete  resection  (OR  3.36,  p  =  0.013).  Recurrence  has
lso  been  associated  with  resection  of  more  pieces  of  LST.70
 retrospective  Japanese  study71 demonstrated  a  signiﬁ-
antly  lower  recurrence  after  ESD  than  after  piecemeal  EMR
2%  vs  14%,  p  <  0.0001),  and  a  multicenter  study54 reported
 98%  5  yr.  free-recurrence  rate  after  ESD.  Another  study
emonstrated  a signiﬁcant  increase  in  the  number  of  endo-
copic  procedures  in  lesions  >40  mm  (p  <  0.001)  and  a  greater
eed  for  surgical  treatment  (p  <  0.001).72 A  prospective  mul-
icenter  study  in  Japan73 showed  that  signiﬁcant  factors
ssociated  with  recurrence  after  endoscopic  resection  for
arge  colorectal  neoplasia  were  piecemeal  EMR,  granular
ubtype  LSTs,  lesions  ≥40  mm,  no  pre-treatment  magni-
cation,  and  ≤10  years  of  experience  in  conventional
ndoscopic  resection.  This  way,  the  thorough  surveillance
nd  the  complete  removal  of  colorectal  neoplasms  are  of
aramount  importance.  Robertson  et  al.74 have  observed
1(19%)  cases  of  CRC  in  colonoscopic  surveillance,  possibly
ssociated  with  incomplete  resection  of  the  lesions.
.2.  Adverse  events  and  management
mmediate  bleeding  can  occur  in  up  to  10%  of  the  cases
f  polypectomy,  and  can  also  present  as  early  or  late
leeding.75,76 This  complication  could  be  treated  endo-
copically  by  injection  therapy,  endoloop,  argon  plasma
oagulation  and  hemoclips.  Adrenaline  injection  reduces
ost-polypectomy  early  bleeding,  but  not  late  bleeding.
ndoloop  or  hemoclip  could  be  used  as  single  therapy  or  in
ombination  (Fig.  6A--C).  Late  bleeding  can  occur  even  15
ays  after  polypectomy  due  to  the  ulcer  caused  by  the  ther-
al  effect  of  the  procedure.77 Buddingh  et  al.78 found  thatight  colon  lesions  bled  oftener  after  polypectomy,  than  left-
ided  ones  (OR  =  4.67,  p  =  0.001),  and  there  was  an  increase
n  the  bleeding  risk  of  13%  for  each  mm  increase  in  the  polyp
iameter  (OR1.13,  p  <  0.001).
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AFigure  6  (A)  Polypoid  lesion  type  0-Ip;  (B)  Prophylaxis  of  b
In  a  randomized  study  evaluating  two  arms  of  50  resected
polyps  each,  there  was  less  cases  of  post  polypectomy  hem-
orrhage  in  the  group,  which  received  adrenalin  injection  at
the  base  or  pedicle  of  the  polyp  (2%  vs  16%).79
A  metanalysis  pointed  out  that  early  post  polypectomy
bleeding  is  signiﬁcantly  diminished,  when  a  prophylac-
tic  therapy  is  adopted.80 This  study  also  showed  that
combined  therapy  is  more  effective  than  monotherapy
in  the  prophylaxis  of  post  polypectomy  bleeding.  How-
ever  there  was  no  signiﬁcant  reduction  in  late  bleeding
irrespective  of  the  chosen  method,  either  alone  or  in  com-
bination.
Bleeding  is  considered  the  most  common  complication
after  ESD,  occurring  in  0.4--16%  of  the  cases.45,81--83 Fer-
rara  et  al.16 concluded  that  bleeding  was  signiﬁcantly
related  to  malignancy.  The  use  of  preventive  hemoclips
after  endoscopic  resection  is  controversial.  A  randomized
trial84 showed  that  preventive  clipping  did  not  decrease  the
delayed  bleeding  (0.98%  vs  0.96%),  while  the  Japan  Gas-
troenterological  Endoscopy  Society  suggests  that  clipping
may  be  effective  for  patients  with  large  lesions  or  for  those
undergoing  antithrombotic  therapy.12
Perforation  has  been  reported  to  occur  in  0--4%  of
cases.80,85--87 Caputi  et  al.19 reported  in  their  series  a  2.3%
perforation  rate  after  EMR  (all  polypoid  carcinomas).  Swan
et  al.88 described  a  target  sign  as  a  marker  of  muscularis  pro-
pria  resection  and,  therefore,  potential  perforation  during
EMR  of  colorectal  lesions,  with  an  incidence  of  3.8%  for  en
bloc  resection  and  1.6%  for  piecemeal  resection  (p  =  0.16).
An  increased  risk  of  perforation  occurs  in  right-sided  lesions,
because  the  wall  of  the  right  colon  is  thinner.  Delayed  per-
foration  is  rare.  Most  cases  occur  in  the  ﬁrst  14  h  after
resection  and  are  oftener  related  to  ESD.
f
b
w
ding  by  clipping  the  stalk;  (C)  Post-polypectomy  appearance.
A  Japanese  prospective  multicenter  study  demonstrated
hat  age  under  60  years  was  a risk  factor  for  bleeding,  and
n  bloc  resection  and  Vienna  classiﬁcation  types  4--5  were
isk  factors  for  perforation.89
Low  perforation  rates  have  been  reported  for  diagnostic
nd  therapeutic  colonoscopy,  but  serious  complications  with
igh  rates  of  morbidity  and  mortality  can  occur.  Perforations
n  diagnostic  colonoscopy  are  larger  than  those  in  therapeu-
ic  colonoscopy,  with  surgery  traditionally  been  indicated
or  the  former  and  usually  a  conservative  approach  for  the
atter.90,91 Kim  JS  et  al.92 had  successful  endoscopic  closure
n  81.3%  of  diagnostic  colonoscopy-associated  perforation
atients.  This  suggests  that  immediate  endoscopic  closure
ith  clips  can  be  attempted  for  diagnostic  perforations
s  well  as  therapeutic  colonoscopy-associated  perforations.
he  sigmoid  colon  is  known  as  the  most  frequent  perforation
ite.  Perforation  rates  for  ESD  were  signiﬁcantly  higher  than
hose  for  polypectomy  or  EMR  (p  <  0.01).93 Lesions  >  40  mm
OR  3.90,  p  <  0.001)  and  location  at  the  ileocecal  valve
OR  2.13,  p <  0.01)  are  recognized  as  strong  risk  factors  for
dverse  events  in  endoscopic  procedures.94 Polypectomies
erformed  by  unexperienced  endoscopists  were  shown  to
ave  almost  a  three-fold  increase  in  the  risk  of  complications
OR  2.96,  p  =  0.0008).95
.3.  Early  colorectal  cancer
ccording  to  the  2014  guidelines  of  the  Japanese  Society
or  Cancer  of  the  Colon  and  Rectum,96 carcinomas  treated
y  endoscopic  resection  are  considered  cured  if  they  are  T1
ith  a  tumor-negative  vertical  margin,  well  or  moderately
ifferentiated,  with  a  submucosal  invasion  depth  <1000  m,
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bsence  of  vascular  invasion  with  tumor  budding  grade  1.  T1
arcinomas  should  have  additional  surgical  treatment  if  they
resent  a  tumor-positive  vertical  margin,  vascular  invasion,
re  poorly  differentiated,  have  submucosal  invasion  depth
1000  m  and  the  tumor  budding  is  graded  as  2  or  3.
. Conclusions
arge  colorectal  lesions  (≥20  mm)  tend  to  present  with
dvanced  histology,  are  more  difﬁcult  to  resect  and  are
ssociated  with  more  complications  after  endoscopic  ther-
py.  Although  these  caveats,  endoscopic  treatment  is  an
ffective  therapy  for  large  colorectal  neoplasms,  even  the
alignant  ones,  and  may  be  done  en  bloc  or  by  piece-
eal  resection,  depending  on  the  morphology  of  the  lesion
r  local  expertise,  although  lesions  should  preferably  be
esected  en  bloc. Proper  lesion  evaluation  with  magniﬁca-
ion  and  chromoendoscopy  (either  virtual  or  real),  EUS  or
RI  should  be  performed  prior  to  removal  depending  on
esion  site,  morphology  or  availability  of  these  methods.
urgical  resection  should  be  reserved  for  those  cases  with
assive  submucosal  invasion  or  other  unfavorable  patholog-
cal  features.
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